FDA recognition of consensus standards in the premarket notification program

Area of Science:

• Regulatory Science
• Medical Device Regulation
• Standards Development

Background:

• The U.S. Food and Drug Administration (FDA) has historically promoted standards for medical device safety and effectiveness.
• FDA reengineering efforts, driven by increased workload and reduced resources, highlighted the need for efficient regulatory processes.
• The FDA Modernization Act of 1997 (FDAMA) mandates the use of standards in the medical device review process.

Purpose of the Study:

• To outline the FDA's strategic plans for integrating consensus standards into the medical device review process.
• To detail the development of a standards recognition process for regulatory review.
• To highlight the anticipated benefits of using standards for both the FDA and medical device manufacturers.

Main Methods:

• The FDA will recognize select consensus standards for use in the device approval process.
• Under the new 510(k) paradigm, manufacturers can submit declarations of conformity to standards as evidence of safety and effectiveness.
• The International Electrotechnical Commission (IEC) 60601 series was the first set of standards chosen for regulatory review.

Main Results:

• Manufacturers can now submit declarations of conformity to recognized standards, bypassing traditional review processes.
• The FDA has published a list of recognized standards in the Federal Register.
• Other standards from recognized organizations like AAMI may also be eligible for use in regulatory review.

Conclusions:

• The adoption of standards in the device review process is expected to save the FDA considerable resources.
• This initiative aims to reduce regulatory obstacles, facilitating market entry for domestic and international manufacturers.
• Reliance on declarations of conformity to recognized standards enhances efficiency and promotes medical device safety and effectiveness.